In this file photo dated April 27, 2021, Hong Kong Secretary for Food and Health Sophia Chan Siu-chee holds a press conference at Central Government Offices. (CALVIN NG / CHINA DAILY)
HONG KONG - The Hong Kong Special Administrative Region government is considering donating any surplus COVID-19 vaccines to places that need them more, Secretary for Food and Health Sophia Chan Siu-chee said Wednesday.
In a written reply to a query at the Legislative Council, Chan said the government is considering either postponing or canceling vaccine deliveries or donating surplus vaccines through the World Health Organization to avoid vaccine wastage.
Secretary for Food and Health Sophia Chan said the government is considering either postponing or canceling vaccine deliveries or donating surplus vaccines through the World Health Organization to avoid vaccine wastage
“In view of the serious vaccine hesitancy in Hong Kong, the chance of the procured vaccines being in surplus is high,” Chan said.
ALSO READ: Nearly 2m vaccine jabs given in Hong Kong
“To avoid wastage amid tight global supply, the government will, based on the vaccination and appointment trends, estimate the quantity of vaccines that may become excessive, and discuss with the drug manufacturers how to handle the expected surplus doses which are unused in this phase of the Vaccination Programme within this year or before their expiry dates,” she added.
Chan noted that the vaccines have “a relatively short expiry date" and expire around three to four months after arrival in Hong Kong.
So far, the government has procured a total of 15 million doses of the Sinovac and Comirnaty vaccines for emergency use, which is sufficient to vaccinate the entire population of Hong Kong, Chan said.
As of May 24, out of the two million odd doses each of the Sinovac and Comirnaty vaccine which have arrived in Hong Kong, there are 1.05 million and 840,000 unused doses, respectively, according to a government statement.
It added that public demand for the Comirnaty vaccine has “gradually become sluggish recently” and that the Comirnaty vaccines now in storage will expire by mid-August this year.
Chan said the two million odd doses of the Comirnaty vaccine that have arrived in Hong Kong do not include the 1.19 million odd doses that had to be returned to the German manufacturer BioNTech due to packaging defects.
“The Comirnaty vaccine needs to be stored in an ultra-low temperature setting, but the storage space of chilled warehouses meeting such requirement is limited,” Chan said.
“If the quantity of uptake falls short of the quantity procured, some of the precious vaccines will be wasted,” she added.
Chan said over 1.26 million persons had received their first dose, accounting for 19.3 per cent of the population aged 16 or above, and about 907,000 persons had received their second dose.
However, the city’s vaccination rate is still far below the level required for achieving herd immunity, Chan said.
“We appeal to those who have not received vaccination to get vaccinated as soon as possible to protect themselves and others, thereby building up the herd immunity barrier for Hong Kong,” she added.
Chan said the government was also already preparing to provide a booster dose in the next phase of the inoculation drive to those already vaccinated.
“As far the Comirnaty vaccine is concerned, according to media reports and information made public by the manufacturer, it is very likely that vaccine recipients will need a third booster dose within 12 months of receiving their second dose, and thereafter a booster dose will be required every year to enhance the efficacy of the vaccine, particularly in regard to the mutant variants,” Chan said.
“It is understood that the manufacturer is conducting research on the interval for booster injections and the safety, immunogenicity and efficacy of the booster dose,” she added.
Chan also said that since Hong Kong has a sufficient supply of vaccines “for the time being and it is important to avoid wastage amid global shortage,” the government did not not see a need for the AstraZeneca vaccine to be delivered to the HKSAR within this year.
Copyright 1995 - 2022. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily. Without written authorization from China Daily, such content shall not be republished or used in any form.
HONG KONG NEWS